Previous 10 | Next 10 |
2024-01-20 09:45:00 ET Eli Lilly (NYSE: LLY) and Meta Platforms (NASDAQ: META) don't seem to have much in common as they operate entirely different businesses in completely different industries. The former is a leader in the biotech industry, while the latter is a social med...
2024-01-20 08:35:00 ET Summary The Magnificent 7 mega-cap corporations have outperformed the S&P 500, and some now have market caps as large as entire developed economies. The dominance of these companies in the stock market is reminiscent of the dot-com bubble in 2000. Th...
2024-01-20 06:50:00 ET Many stocks that have delivered big gains eventually succumb to the investing equivalent of gravity. However, not all of them do. Some keep the momentum going and going. Three Motley Fool contributors think that they've found high-flying stocks that can go much hi...
2024-01-19 15:26:30 ET Summary Eli Lilly and Company stock has delivered almost 5x returns in the past five years, with an almost 100% upsurge in the last 12 months alone. Eli Lilly's success is attributed to its focus on obesity/diabetes drugs, with currently available blockbuste...
2024-01-19 11:18:03 ET More on Eli Lilly Eli Lilly: The Buzz Is Not Over Eli Lilly and Company (LLY) JPMorgan 42nd Annual Healthcare Conference Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly Lilly, Novo Nordisk diabetes drugs see price raises -...
2024-01-19 08:05:15 ET More on Bristol-Myers, J&J, etc. Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off? Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuits And Ambrx Acquisition Bristol-Myers Squibb: Big Dividend Yield, Unl...
2024-01-19 08:00:00 ET Summary The healthcare sector is overvalued by 12.5% based on 11-year averages. Nevertheless, the healthcare providers industry shows a good value score. iShares U.S. Healthcare ETF is an unattractive alternative to XLV. We look at 10 healthcare stocks c...
2024-01-19 07:59:00 ET Summary Congress passes stopgap spending bill to avert government shutdown and buy more time for funding negotiations. Prices of diabetes drugs Mounjaro and Ozempic see increases, along with hundreds of other drugs. Nasdaq 100 reaches all-time high, driv...
2024-01-18 18:36:01 ET A healthcare stock that's been on quite a run so far this young year, Eli Lilly (NYSE: LLY) took a bit of a pause on Thursday. Its price sagged by nearly 1% on the day, in contrast to the S&P 500 index's gain of nearly that amount, on the back of a med...
2024-01-18 14:41:08 ET More on Eli Lilly, Novo Nordisk Taking Novo Nordisk To The Next Level Novo Nordisk: Enjoying The Tailwinds Of A Growing Market Eli Lilly: The Buzz Is Not Over Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 07:07:00 ET If your portfolio doesn't have exposure to the biopharma businesses pursuing the development of weight loss medicines, it might be time to consider changing that situation. With an influx of new drugs for sale, and many competitors looking to secure their share of the...
2024-07-30 05:48:00 ET Going into 2024, DexCom 's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from individuals with diabetes. However, last week was the worst for De...
2024-07-29 15:13:21 ET Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics Inc and Roche Holding AG, who made announcements regarding th...